Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIVHIV 감염자에서 COVID-19 mRNA 백신 3차 접종에 대한 면역원성Article Published on 2022-08-222022-09-12 Journal: Nature Communications [Category] SARS, 임상, 진단, 치료기술, [키워드] advanced disease age AIDS anti-RBD ART BNT162b2 CD4 Cell-mediated immunity Combination COVID-19 dose generally mild Heterologous Humoral response IFN-γ immune dysregulation immunogenicity log median microneutralization mRNA vaccine mRNA-1273 PLWH receiving recorded SARS-CoV-2 vaccine second dose Side-effect Support with HIV [DOI] 10.1038/s41467-022-32263-7 PMC 바로가기 [Article Type] Article
Effects of side-effect risk framing strategies on COVID-19 vaccine intentions: a randomized controlled trialRandomized Controlled Trial Published on 2022-08-162022-10-05 Journal: eLife [Category] 임상, [키워드] Adding Affect behavior change change clinical conducted COVID-19 COVID-19 vaccine driver Effect Epidemiology Evidence fear global health Human independent individual Mortality nudges participant population level presenting Randomized controlled trial receive reduce registry risk Risk communication Safe severity Side-effect the United State the vaccine Trial United Kingdom Vaccine Vaccine hesitancy vaccine hesitancy. vaccine intention [DOI] 10.7554/eLife.78765 PMC 바로가기 [Article Type] Randomized Controlled Trial
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID StudyCOVID-19 백신 약화 및 부스터의 효과 및 부작용: ZOE COVID 연구의 전향적 커뮤니티 연구Article Published on 2022-07-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI Adverse reaction Adverse reactions Alpha Analysis B.1.1.7 BNT162b2 booster booster dose booster doses ChAdOx1 ChAdOx1 nCoV-19 chronic chronic disease Community community setting Comorbidities completion confounder confounders Control country COVID COVID-19 COVID-19 vaccine dose effective Effectiveness fatigue foundation group Heterologous heterologous schedule heterologous schedules homologous schedule individual Infection investigated Local local symptom Medical Research Council mRNA mRNA-1273 mRNA1273 nCoV new SARS-CoV-2 Odds ratio Older participant Participants Pfizer-BioNTech Poisson regression model positive reactogenicity receiving regimens remained reported SARS-CoV-2 SARS-CoV-2 positivity SARS-CoV-2 test second dose self-reported systemic Side-effect Side-effects Symptom systemic systemic side-effect Systemic side-effects systemic symptom tenderness test result tested those with comorbidities vaccinated individual vaccinated individuals vaccination Vaccine vaccine dose variant variants waned Wellcome Trust [DOI] 10.1016/S1473-3099(22)00146-3 PMC 바로가기 [Article Type] Article
SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy전신 경화증 환자의 SARS-CoV-2 백신: 질병 하위 유형 및 치료의 영향Clinical Trial Published on 2022-06-282022-09-12 Journal: Rheumatology (Oxford, England) [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] affected affecting anti-SARS-CoV-2 Antibody Response baseline comparable Control controls CoronaVac disease dose Factor first dose Follow-up Frequency immunogenicity immunosuppressive inactivated individual Interstitial lung disease majority median age MMF moderate monotherapy Most patient Multiple mycophenolate neutralizing antibody Participants Patient Prospective Study regression analysis respiratory safety profile SARS-CoV-2 SARS-CoV-2 vaccine Seroconversion Side-effect subgroup of patients Systemic sclerosis therapy Trial vaccination Vaccine vaccine response vaccine. were assessed [DOI] 10.1093/rheumatology/keab886 PMC 바로가기 [Article Type] Clinical Trial
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults성인에서 RBD-이량체 기반 코비드-19 백신 ZF2001의 효능 및 안전성Clinical Trial Published on 2022-06-022022-09-25 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 신약개발, 임상, 진단, [키워드] 1:1 95% CI 95% confidence interval acute respiratory syndrome Adults adverse event Adverse reaction age aluminum Analysis assigned China Clinical Center clinical trials conducted coronavirus coronavirus disease Cutoff death deaths dimeric dose double-blind effective Efficacy efficacy analysis efficacy end point Follow-up hydroxide immunogenic incidence Indonesia large cohort Major MOST occurred Occurrence participant Participants phase 3 trial Placebo placebo-controlled primary end point primary end-point Randomized Randomly receive regimen reported Safe Safety safety analysis Science Serious Adverse Event shown Side-effect symptomatic technology the placebo group the receptor-binding domain Trial two groups vaccination Vaccine was performed ZF2001 [DOI] 10.1056/NEJMoa2202261 PMC 바로가기 [Article Type] Clinical Trial
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysisReview Published on 2022-06-012023-07-08 Journal: Digestive and liver disease : official journal of [Category] COVID19(2023년), [키워드] Crohn's disease SARS-CoV-2 Side-effect ulcerative colitis. [DOI] 10.1016/j.dld.2022.03.005 PMC 바로가기 [Article Type] Review
Face masking and COVID-19: potential effects of variolation on transmission dynamics안면 마스크와 COVID-19: 변이가 전파 역학에 미치는 잠재적 영향Article Published on 2022-05-012022-09-11 Journal: Journal of the Royal Society Interface [Category] COVID19(2023년), SARS, 변종, [키워드] acquired immunity attack rate basic reproduction number cause COVID-19 Delta Differential equations dose Effect Effectiveness Epidemic epidemiological estimate face Face mask Face masks growth growth rate healthcare Immunity individual induce Infection infections Infectious diseases infectious dose initial Live virus Mask masking Metrics omicron parameter Particles pre-vaccination Prevalence Prevent reduce reducing respiratory infections SARS-CoV-2 severe disease severe infections Side-effect SIR model smallpox suggested susceptible individual susceptible individuals Transmission Transmission dynamics transmission rate variants variolation variolation. wild-type virus [DOI] 10.1098/rsif.2021.0781 PMC 바로가기 [Article Type] Article
Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart reviewReview article Published on 2022-05-012022-10-05 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), SARS, 진단, [키워드] cellular complications coronavirus 2019 (COVID-19) coronavirus disease COVID-19 COVID-19 mRNA vaccine COVID-19 myocarditis COVID-19 perimyocarditis COVID-19 vaccination disease Healthcare system Hospitalization hypothetical Mortality mRNA vaccine mRNA vaccines myocarditis pandemic Pathogenesis pathogenesis of COVID-19 pathophysiology post vaccination reduced regimen reported SARS-CoV-2 Severe COVID-19 Infection Side effect Side-effect significantly Takotsubo syndrome therapeutic with COVID-19 [DOI] 10.1016/j.biopha.2022.112843 [Article Type] Review article
Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave백신 출시 및 세 번째 COVID-19 물결 동안 이스라엘의 40세 미만 인구에서 응급 심혈관 사건 증가Article Published on 2022-04-282022-09-11 Journal: Scientific Reports [Category] 치료제, [키워드] Acute coronary syndrome Administered age association binomial Cardiac arrest cardiovascular cardiovascular event causal relationship causal relationships caused causes condition coronary syndrome coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 vaccine COVID-19 vaccines dataset Emergency evaluate Factor Health identify IMPROVE Increased individuals Infection infection rates myocarditis negative outcome public health raise regression models reported service Side-effect Side-effects significantly Surveillance unique vaccination rates Vaccine vaccine dose Volume while with COVID-19 [DOI] 10.1038/s41598-022-10928-z PMC 바로가기 [Article Type] Article
Public attitudes and influencing factors toward COVID-19 vaccination for adolescents/children: a scoping reviewReview article Published on 2022-04-012022-10-05 Journal: Public health [Category] 변종, [키워드] adolescents affecting age analyzed Attitude Characteristics children Cochrane Library COVID-19 COVID-19 vaccination develop Effectiveness Elsevier Factor Gender Immunity Intervention measure objective pandemic parents Public ranged Result scoping review screened Side-effect the vaccine vaccination Vaccine Web of Science [DOI] 10.1016/j.puhe.2022.02.002 [Article Type] Review article